Cargando…
Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) Vaccination
ZOSTAVAX(®) is a live attenuated varicella-zoster virus (VZV) vaccine that is licensed for the protection of individuals ≥50 years against shingles and its most common complication, postherpetic neuralgia. While IFNγ responses increase upon vaccination, the quality of the T cell response has not bee...
Autores principales: | Sei, Janet J., Cox, Kara S., Dubey, Sheri A., Antonello, Joseph M., Krah, David L., Casimiro, Danilo R., Vora, Kalpit A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629102/ https://www.ncbi.nlm.nih.gov/pubmed/26579128 http://dx.doi.org/10.3389/fimmu.2015.00553 |
Ejemplares similares
-
Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures
por: Cox, Kara S., et al.
Publicado: (2015) -
Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults
por: Choi, Won Suk, et al.
Publicado: (2016) -
Herpes zoster vaccine (Zostavax®): Cellulitic injection site reaction or bacterial cellulitis?
por: Cook, Ian F.
Publicado: (2016) -
Vaccination with Ad5 Vectors Expands Ad5-Specific CD8(+) T Cells without Altering Memory Phenotype or Functionality
por: Hutnick, Natalie A., et al.
Publicado: (2010) -
Performance of Zoster Vaccine Live (Zostavax): A Systematic Review of 12 years of Experimental and Observational Evidence
por: Dooling, Kathleen, et al.
Publicado: (2017)